MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)

Meeting: 2025 International Congress

Keywords: Dystonia: Genetics, Myoclonus: Genetics, Paroxysmal dyskinesia

Category: Pediatric Movement Disorders

Objective: To describe the clinical presentation, diagnostic evaluation, and genetic findings in a 7-year-old male with a hyperkinetic movement disorder associated with a novel GNAI1 variant, expanding the phenotypic spectrum of GNAI1-related disorders.

Background: Pathogenic variants in genes, such as GNAO1, encoding G-protein coupled receptor (GPCR) associated proteins have been linked to broad phenotypes encompassing hyperkinetic movement disorders, epilepsy, and intellectual disability (ID). GPCRs are involved in post-synaptic signaling modulation and cyclic adenosine monophosphate (cAMP) metabolism. GNAI1 encodes the GPCR-associated alpha-i1 subunit (Gα1) and has been described in cases with ID and epilepsy but has not previously been reported in association with movement disorders.

Method: We performed detailed clinical characterization, neuroimaging, electroencephalography (EEG), and whole genome sequencing in a 7-year-old boy presenting with a complex hyperkinetic movement disorder.

Results: We describe a 7-year-old boy with history of prematurity and in utero substance exposure who presented with a complex hyperkinetic movement disorder characterized by dystonia, myoclonus, and paroxysmal dyskinesias. The most disabling feature was a myoclonic tremor, which significantly impaired his ability to use eating and writing utensils. Paroxysmal dyskinetic movements triggered by running contributed to falls. Interictal dystonia was mild. Brain magnetic resonance imaging showed white matter abnormalities associated with prematurity. Prolonged EEG monitoring was unremarkable. Whole genome sequencing identified a likely pathogenic GNAI1 variant (c.64A>T). Disabling myoclonic tremor responded to clonazepam treatment.

Conclusion: This case report expands the phenotypic spectrum of GNAI1-related disorders to include paroxysmal and chronic hyperkinetic movement disorders. The findings suggest that GNAI1 should be considered alongside other GPCR-related disorders in the differential diagnosis of childhood-onset complex hyperkinetic movement disorders associated with ID, particularly when myoclonic tremor is a prominent feature. Recognition of this association may facilitate diagnosis and guide therapeutic interventions.

To cite this abstract in AMA style:

T. Larsh, A. Espay, D. Gilbert, S. Wu. GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/gnai1-associated-childhood-onset-hyperkinetic-movement-disorder-a-case-report/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gnai1-associated-childhood-onset-hyperkinetic-movement-disorder-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley